Sub. H.B. No. 167 - Daniel's Law

• Provides liability protection for persons administering naltrexone by injection if the individual cannot receive treatment from their regular provider and specific conditions are met, including authorization by the employer or facility.

• Requires prescribers (advanced practice nurses, physicians, and physician assistants) to inform patients about all FDA-approved medication-assisted treatment options in writing and orally before initiating treatment.

• Permits pharmacists to dispense naltrexone without a prescription if a previous prescription record exists, the prescriber cannot be reached, and the pharmacist determines the drug is necessary to continue substance use disorder treatment; limits oral form to five-day supply.

• Restricts advanced practice nurses, physician assistants, and physicians who fail to comply with medication-assisted treatment requirements to treating no more than 30 patients at one time with such treatment.

• Requires the Department of Mental Health and Addiction Services to adopt rules governing compliance with medication-assisted treatment requirements for practitioners working at community addiction services providers.